KR101152308B1 - 항구토제와 엔케팔리나제 억제제의 배합물 - Google Patents

항구토제와 엔케팔리나제 억제제의 배합물 Download PDF

Info

Publication number
KR101152308B1
KR101152308B1 KR1020067016159A KR20067016159A KR101152308B1 KR 101152308 B1 KR101152308 B1 KR 101152308B1 KR 1020067016159 A KR1020067016159 A KR 1020067016159A KR 20067016159 A KR20067016159 A KR 20067016159A KR 101152308 B1 KR101152308 B1 KR 101152308B1
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
combination
diarrhea
treatment
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020067016159A
Other languages
English (en)
Korean (ko)
Other versions
KR20060132691A (ko
Inventor
장 샤를 슈워츠
잔느 마리 르꽁뜨
Original Assignee
비오프로제
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101152308(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 비오프로제 filed Critical 비오프로제
Publication of KR20060132691A publication Critical patent/KR20060132691A/ko
Application granted granted Critical
Publication of KR101152308B1 publication Critical patent/KR101152308B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
KR1020067016159A 2004-02-12 2005-02-14 항구토제와 엔케팔리나제 억제제의 배합물 Expired - Fee Related KR101152308B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04290384.9 2004-02-12
EP04290384A EP1563848A1 (en) 2004-02-12 2004-02-12 New combinations of an anti-emetic agent and an enkephalinase inhibitor
PCT/IB2005/000351 WO2005079850A1 (en) 2004-02-12 2005-02-14 New combinations of an anti emetic agent and an enkephalinase inhibitor

Publications (2)

Publication Number Publication Date
KR20060132691A KR20060132691A (ko) 2006-12-21
KR101152308B1 true KR101152308B1 (ko) 2012-06-11

Family

ID=34684783

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067016159A Expired - Fee Related KR101152308B1 (ko) 2004-02-12 2005-02-14 항구토제와 엔케팔리나제 억제제의 배합물

Country Status (28)

Country Link
US (1) US8222294B2 (enExample)
EP (2) EP1563848A1 (enExample)
JP (1) JP4987487B2 (enExample)
KR (1) KR101152308B1 (enExample)
CN (1) CN1917903B (enExample)
AT (1) ATE468138T1 (enExample)
AU (1) AU2005215262B2 (enExample)
BR (1) BRPI0506631B8 (enExample)
CA (1) CA2553827C (enExample)
CY (1) CY1110202T1 (enExample)
DE (1) DE602005021317D1 (enExample)
DK (1) DK1718337T3 (enExample)
EA (1) EA010625B1 (enExample)
EC (1) ECSP066758A (enExample)
ES (1) ES2344909T3 (enExample)
HR (1) HRP20100363T1 (enExample)
MA (1) MA28354A1 (enExample)
ME (1) ME01175B (enExample)
NO (1) NO337320B1 (enExample)
NZ (1) NZ548635A (enExample)
PL (1) PL1718337T3 (enExample)
PT (1) PT1718337E (enExample)
RS (1) RS51329B (enExample)
SI (1) SI1718337T1 (enExample)
TN (1) TNSN06246A1 (enExample)
UA (1) UA88156C2 (enExample)
WO (1) WO2005079850A1 (enExample)
ZA (1) ZA200605872B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900823B1 (fr) * 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
EP2462922A1 (en) * 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
EP2866789B1 (en) 2012-06-28 2018-08-01 Johnson & Johnson Consumer Inc. Racecadotril lipid compositions
US9114171B2 (en) * 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
US9801819B2 (en) * 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
PT2866802T (pt) * 2012-06-28 2016-09-05 Johnson & Johnson Consumer Inc Composições líquidas racecadotril
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANNALS OF EMERGENCY MEDICINE 3 9:4, 397-403, APRIL 2002 *
ANNALS OF EMERGENCY MEDICINE 3 9:4, 397-403, APRIL 2002*
International Journal of Antimicrobial Agents 14 (2000) 81-87 *
International Journal of Antimicrobial Agents 14 (2000) 81-87*

Also Published As

Publication number Publication date
ATE468138T1 (de) 2010-06-15
CY1110202T1 (el) 2015-01-14
DK1718337T3 (da) 2010-07-26
JP4987487B2 (ja) 2012-07-25
CA2553827C (en) 2012-08-07
SI1718337T1 (sl) 2010-08-31
AU2005215262B2 (en) 2011-03-03
MA28354A1 (fr) 2006-12-01
US8222294B2 (en) 2012-07-17
ECSP066758A (es) 2006-11-24
KR20060132691A (ko) 2006-12-21
BRPI0506631B8 (pt) 2021-05-25
CA2553827A1 (en) 2005-09-01
NO20063973L (no) 2006-09-05
EP1718337B1 (en) 2010-05-19
US20070275993A1 (en) 2007-11-29
AU2005215262A1 (en) 2005-09-01
ZA200605872B (en) 2008-01-08
BRPI0506631A (pt) 2007-05-08
EP1718337A1 (en) 2006-11-08
JP2007522202A (ja) 2007-08-09
NO337320B1 (no) 2016-03-07
EA010625B1 (ru) 2008-10-30
PT1718337E (pt) 2010-06-16
DE602005021317D1 (de) 2010-07-01
NZ548635A (en) 2009-10-30
CN1917903A (zh) 2007-02-21
CN1917903B (zh) 2010-07-21
WO2005079850A1 (en) 2005-09-01
ES2344909T3 (es) 2010-09-09
BRPI0506631B1 (pt) 2018-12-04
ME01175B (me) 2013-03-20
EP1563848A1 (en) 2005-08-17
EA200601466A1 (ru) 2006-12-29
RS51329B (sr) 2011-02-28
UA88156C2 (ru) 2009-09-25
TNSN06246A1 (fr) 2007-12-03
PL1718337T3 (pl) 2010-09-30
HRP20100363T1 (hr) 2010-07-31

Similar Documents

Publication Publication Date Title
US20100273807A1 (en) Use of PDE III Inhibitors for the Treatment of Asymptomatic (Occult) Heart Failure
CZ284363B6 (cs) Použití protikřečových činidel k přípravě léčiv určených k léčení Parkinsonovy choroby a Parkinsonových syndromů
SK279046B6 (sk) Použitie 2-amino-6-trifluórmetoxybenzotiazolu na z
EP1986642A1 (en) Combination of alpha-2 receptor agonist (clonidin) and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea
RU2284819C2 (ru) Стабильная пероральная твердая композиция лекарственного препарата
EP2254575B1 (en) Oral l-histidine for the treatment or prevention of atopic dermatitis or contact dermatitis
KR20060132691A (ko) 항구토제와 엔케팔리나제 억제제의 배합물
US12414935B2 (en) Compounds and methods for the treatment of parasitic diseases
JPH05132430A (ja) 薬物従属症及び禁断症状の治療に関するグリシン／ｎｍｄａレセプターリガンドの用法
CN108992456A (zh) 含有香叶木苷硫酸酯衍生物的药物组合物及其应用
US20030069279A1 (en) Antimicrobial agent
US7842702B2 (en) Treatment for irritable bowel syndrome
JPH09500646A (ja) アザスピランによるｈｉｖの治療法
KR101329349B1 (ko) 중탄산염을 포함하는 염소 흔들이병 치료용 약학적 조성물
KR100593795B1 (ko) 안정성이 개선된 라미프릴을 포함하는 경구투여용 제제
JPS625923A (ja) アレルギ−性疾患治療剤
CZ367598A3 (cs) Použití substituovaného azaspiranu
KR20010033001A (ko) 알콜성 위염 예방제
JPH10503202A (ja) アザスピラン類を用いる日和見感染の治療方法
IL96797A (en) Manufacture of pharmaceutical compositions containing 1,2,3,9- tetrahydro-3-((1H-imidazol-1-YL)methyl)-4H-carbazol-4-one for treatment of impaired approach oriented behavior in stressful situations, for increasing vigilance and for treatment of rhinitis or lung embolism
JPH05201876A (ja) Ｆｋ５６５の副作用軽減剤

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20150427

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20160425

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20170425

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20180425

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20190425

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20210526

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20210526